OrthoPediatrics (KIDS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Apr, 2026Executive summary
Annual meeting scheduled for June 4, 2026, at The St. Louis Club, St. Louis, Missouri, at 11:30 A.M. Eastern Time.
Proxy materials and annual report are available online, with options for electronic or paper delivery.
Shareholders can vote online, by phone, or by mail, with electronic votes due by June 4, 2026, at 1:00 A.M. Eastern Time.
Voting matters and shareholder proposals
Election of four directors to serve until the 2029 annual meeting: George S. M. Dyer, MD; Kelly Fischer; David R. Pelizzon; Harald Ruf.
Advisory vote to approve executive officer compensation as disclosed.
Proposal to amend the 2024 Incentive Award Plan.
Advisory vote to approve Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and FOR all proposals on the ballot.
Proxy allows for discretionary voting on other business that may arise at the meeting.
Latest events from OrthoPediatrics
- Q1 2026 revenue rose 13% to $59.4M, adjusted EBITDA turned positive, and guidance was raised.KIDS
Q1 20265 May 2026 - New product launches and regulatory shifts are fueling growth and expanding market share.KIDS
The Citizens Life Sciences Conference 20264 May 2026 - 2026 outlook targets double-digit growth and profitability, fueled by innovation and global expansion.KIDS
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - Director elections, compensation, plan amendment, and auditor approval headline the annual meeting.KIDS
Proxy filing20 Apr 2026 - Clinic growth, innovation, and stable margins drive strong performance and future expansion.KIDS
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - Record 2025 revenue, double-digit Q4 growth, and strong 2026 outlook with positive cash flow.KIDS
Q4 20257 Apr 2026 - Projected 2026 revenue up to $266M, with breakeven adjusted EBITDA and positive free cash flow.KIDS
Investor presentation26 Feb 2026 - Record growth in pediatric orthopedics, driven by innovation and expanding specialty bracing.KIDS
Canaccord Genuity’s 45th Annual Growth Conference3 Feb 2026 - Specialty bracing and clinic expansion are fueling rapid, scalable growth in pediatric orthopedics.KIDS
2024 Truist Securities MedTech Conference3 Feb 2026